Philip R. Johnson M.D.

Chief Executive Officer at Interius Biotherapeutics

Philip R. Johnson, MD, serves as the Chief Executive Officer of Interius Biotherapeutics since 2021 and has been a Biotechnology Consultant at Caicos Partners since 2016. Johnson held various significant roles including Venture Partner at Apple Tree Partners (2019-2020), President & Chief Scientific Officer at Limelight Bio (2016-2020), and Medical Advisor at CompuVax (2016-2019). Johnson was also a Senior Advisor at the International AIDS Vaccine Initiative (IAVI) (2016-2017) and spent a decade at The Children's Hospital of Philadelphia as Executive Vice President & Chief Scientific Officer while serving as a Professor at the University of Pennsylvania during the same time. Earlier career milestones include serving as President of the Children's Research Institute at Nationwide Children's Hospital (1996-2004) and as a Professor at The Ohio State University (1991-2004). Johnson's educational background includes a Doctor of Medicine degree and a Bachelor’s Degree in Chemistry and Interdisciplinary Studies from the University of North Carolina at Chapel Hill, along with a Staff Fellow designation from the National Institutes of Health in the Laboratory of Infectious Diseases.

Location

Philadelphia, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Interius Biotherapeutics

1 followers

Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.


Industries

Employees

11-50

Links